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Pharmaceutical companies increasingly must 
consider patients’ needs in drug development. Since 
patients’ needs are often difficult to measure, 
especially in rare diseases, information in drug 
development decision-making is limited. In the 
proposed study, we employ the opportunity algorithm 
to identify and prioritize unmet medical needs of 
multiple sclerosis patients shared in social media 
posts. Using topic modeling and sentiment analysis 
features of the opportunity algorithm are generated. 
The result implies that sensory problems, pain, mental 
health problems, fatigue and sleep disturbances 
represent the highest unmet medical needs of the 
samples population. The present study suggests a 
promising potential of this method to provide relevant 
insights into rare disease populations to promote 
patient-centered drug development. 
1. Introduction  
Pharmaceutical companies increasingly need to 
consider perspectives and needs of patients in drug 
development, responding to changes in the business 
environment. For example, patient-reported outcomes 
are considered by regulatory authorities in the 
approval, pricing, and reimbursement decision-
making [1]. Furthermore, in the (Food and Drug 
Administration) FDA's Patient-Focused Drug 
Development initiative patients perspectives on 
treatment benefits are considered in the approval 
process [2]. Therefore, the patient’s perceived benefit 
of a new treatment is increasingly important for 
commercial success.  Thus, pharmaceutical companies 
need to address the unmet medical needs of a patient 
population, not only by increasing clinical outcomes, 
e.g., controlling the underlying disease progression, 
but improving outcomes relevant from patients’ 
everyday perspective. Therefore, pharmaceutical 
companies have to consider unmet medical needs 
(UMNs) in their portfolio management systematically 
[3] as well as in overall drug development – referred 
to as “Patient-Centered-Drug-Development” (PCDD) 
[4]. The patient UMN is determined by the difference 
between the health status achieved with the current 
standard of care (SoC) and the patient’s ideal health 
status (absence of the disease) [3]. In the context of 
PCDD, ideal health status is determined by the 
patients´ preferences [4]. However, evidence 
regarding UMNs and the impact on patients’ life is 
often limited, especially in rare diseases [5]. In 
addition, clinicians and patients perceive UMNs 
differently [6]. This may lead to pursuing the 
improvement of less relevant therapeutic outcomes in 
clinical developments [6]. For example, a recent study 
on the quality of life of patients with multiple sclerosis 
(MS) demonstrated that MS patients and physicians 
differed in their assessment of the impact of different 
UMNs on quality of life [5]. In the worst case, real 
patient needs are disregarded in drug development and 
opportunities to innovate and to improve patients’ 
quality of life are missed. Simultaneously, the 
development of rare diseases therapies is crucial, to 
improve patients’ life’s as well as for commercial 
success of pharmaceutical companies. Various health 
systems are financially incentivizing research of 
therapies, making the rare disease segment a future 
growth market [7]. Companies participating in the rare 
disease market are already associated with higher 
market value and profits than enterprises without rare 
disease treatments in their portfolio [8].  
In this context, social media data could be 
valuable to inform drug development decision-making 
regarding UMNs perceived by patients [9]. Extant 
research revealed that patients suffering from severe 
diseases use social media platforms to exchange 
information about their diseases-trajectories [10, 11]. 
They exchange experiences about symptoms and 
therapies or use these platforms as a medium to 
support each other emotionally [10, 11]. The 
accumulated available knowledge has already been 





employed for disease-specific research [12-15]. Initial 
studies are exploring the use of social media to explore 
patient needs and preferences of specific disease 
populations for drug development [16, 17]. Cook et al.  
[17] were the first to prove the use of social media 
posts to derive relevant items for patient preference 
studies in the early drug development process of dry 
eye disease (DED) and non-alcoholic steatohepatitis 
[17]. The automated extraction and analysis of social 
media data is referred to as social media mining [18]. 
In this context, we are conducting an initial feasibility 
study to investigate whether relevant UMNs of MS 
patients can be identified and prioritized exclusively 
by using social media mining methods. In addition to 
the commercial value of rare disease treatments for 
pharmaceutical companies, the underlying nature and 
symptoms associated with the disease are particularly 
suited to social media mining [9]. The severe physical 
and psychological limitations along to the rarity of the 
disease cause MS patients using social media as a 
pivotal medium for both information gathering and 
sharing, e.g. about treatment trajectories, as well to 
receive emotional support by the community [9, 10]. 
Specifically, we will implement the theoretical 
framework of the opportunity algorithm (OA) using an 
appropriate social media mining pipeline with several 
natural-language-processing methods. Generating 
insights, OA could be used to guide the drug 
development process by prioritizing therapy outcomes 
that are important to patients while reducing the costs 
incurred by analogous methods.  
2. Background 
Relevant unmet medical needs for decision-
making in pharmaceutical drug development, include 
mortality, time suffering from disease, symptom and 
disease burden, side effects, treatment inconvenience 
and patient perception [3]. Life expectancy can be 
used as a mortality measure. In the MS population life 
expectancy is reduced by 7 to 14 life years compared 
to healthy population [19]. Symptom and disease 
burden consist of disease-related symptoms 
experienced by the individual patient. Green et al. [20] 
assessed the correlation between symptom severity 
and self-perceived health in MS patients by 
performing pearson correlations and multivariate 
linear regressions. They considered walking, hand 
function, vision, fatigue, cognition, bladder, sensory, 
pain, depression, and anxiety as coefficients. Pain 
contributed most to health perception in outpatients 
with multiple sclerosis, followed by walking and 
fatigue [20]. Roemmer et al. [21] investigated side 
effects of MS therapies. Infections are common while 
being treated with immunosuppressive drugs. 
Malignancies were reported in some of the pivotal 
studies. Other adverse effects, such as skin reactions, 
are usually not life threating but may lead to decreased 
therapy adherence [21]. Treatment inconvenience is 
majorly affected by route of administration [22, 23]. 
For instance, injectable treatments are very 
inconvenient. As oral treatments became available, 
patients started switching because of the route of 
administration [22, 23]. Patient perception refers to the 
patient's perceived health as often measured by 
established health-related quality of life questionnaires 
(QoL), such as the Short Form Questionnaire (SF-36) 
[3]. Gil-González [24] conducted a systematic review 
regarding the QoL of adults MS patients. They 
concluded fatigue, pain, and cognitive impairment 
significantly worsen quality of life and should 
therefore be prioritized in diseases treatment [24].  
According to Christensen et al., innovation is 
successful if it addresses a perceived unmet need of 
the customer, also called "the-job-to-be-done" logic 
[25]. As the patients perceived benefit of a new 
treatment is increasingly important for commercial 
success, goal of drug development should be a 
treatment that reduces a perceived unmet medical need 
of patients, and therefore "gets the job done". 
Following the “job-to-be-done” logic, Ulwick  [26] 
derived the opportunity algorithm (OA) to prioritize 
unmet needs as opportunities to innovate. The 
underlying assumption of OA is that successful 
innovation occurs when the new product addresses an 
important - and at the same time - relatively unsatisfied 
need [26]. Therefore, the OA can be used to prioritize 
unmet needs to identify the “job-to-be-done”, which 
should be completed to improve patients’ life [9]. The 
OA is defined as follows [27]: 
Opportunity = Importance + Max (Importance − 
Satisfaction, 0) 
Few studies accessed prioritization of innovation 
opportunities by analyzing social media data in means 
of the OA. Choi et al. [28] concluded that innovation 
opportunities in the smart speaker market exist in 
offering customized commands [28]. Jeong et al. 
found that innovations for smartphones should include 
payment services and fast charging functions [27]. 
Given the encouraging results in consumer markets, 
we evaluate the OA in identifying and prioritizing MS 
patients’ unmet medical needs. To the best of our 
knowledge, this is the first study investigating the OA 
for detecting innovation potential in the context of 
drug development. 
3. Research design and method 
To identify and prioritize MS patients’ unmet 
medical needs, we collected and analyzed posts in a 
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MS online forum. Data extraction was performed 
using web scraping. Similar to Jeong et al. [27] 
accessing innovation opportunities in the smartphone 
market [27], topic modeling is used to identify UMNs 
in MS patients social media posts. Furthermore, we 
assume that a topic that is mentioned more frequently 
than another topic is also more important [27] from the 
patient's perspective. Therefore, as a surrogate for the 
importance of UMN in the context of the opportunity 
algorithm, we use the topic frequency. 
Since the frequency alone is not decisive for an 
unmet need, the OA additionally considers the 
satisfaction regarding the need [26]. Satisfaction is 
derived using sentiment analysis [27]. The results of 
the OA will be evaluated using extant literature. 
3.1 Data Source and Extraction 
Since unmet medical needs comprise several 
different dimensions [3], social media platforms with 
information containing comprehensive aspects of 
patients' disease trajectories are advantageous. 
Therefore, we opted for online forums, which tend to 
contain longer, more detailed posts [10]. Moreover, 
unlike leading commercial platforms employing 
advertising and algorithms [29] to manipulate user 
behavior, online forums do not use algorithms to 
influence discussion and contain less or even forbid 
advertising [9]. After inspecting samples of various 
MS-specific online forums, we chose a forum whose 
content met our criteria (detailed description of the 
disease trajectory and few advertisements) and whose 
data were accessible through web scraping. Using 
Parsehub, a commercial tool for web scraping, we 
collected 119,501 posts (consisting of original and 
follow-up posts) from 01-01-2013 to 31-12-2020 
(Fig.1). 
 
Figure 1. Number of posts collected per year 
3.2 Data Preprocessing  
As described above we will analyze UMNs due to 
the OA. Since social-media content mainly comprises 
unstructured text, the use of natural language 
processing techniques is essential during 
preprocessing to reduce noise and structure the data to 
facilitate insightful analysis [30]. As the requirements 
of topic model and sentiment analysis regarding the 
dataset are significantly different, pre-processing 
differs as well. Hence, we describe applied 
preprocessing methods separately. However, the 
dataset for topic modeling and sentiment analysis is 
prepared using deduplication, reducing data set to 
110,303 unique posts. 
 
3.2.1. Identifying UMNs and their importance 
 
Following, the topic models’ pipeline is outlined, 
aiming to create features for the “importance” 
dimension of the OA. 
 
Word tokenization and lowercasing 
Since our dataset consists of phrases and the topic 
model requires a feature vector consisting of separate 
words, we split the phrases into tokens (words). We 
used the function "word_tokenize()" of the NLTK 
library. All tokens were lower-cased. 
 
Stop words removal  
Stop words occur very frequently (e.g. articles and 
negations) and are meaningless in analysis. Therefore, 
we excluded stop words using the stop word list of the 
NLTK library. Furthermore, we created a custom list 
of stopwords, including common words such as 
“doctor” and “symptom”. 
 
Noun- and Verb- Phrase Extraction 
Noun phrase extraction can be used to improve 
topic coherence [31]. We defined noun phrases as a 
combination of nouns and adjectives. Furthermore, we 
decided to extracted verb-phrases, defined as a verb 
followed by adjective. Verb phrases were assumed to 
be useful in describing symptoms. In implementation 
we used the “nltk.RegexpParser()” function of the ntlk 
python library.  
 
Lemmatization  
Since words appear in several inflected forms, 
eventually worsening topic model results, we used 
lemmatization to improve topic quality by converting 
words into the base form [32]. Lemmatization was 
conducted with the “lemmatizer()” function of the 
spaCy python library.  
 
Page 2993
Keyword-Dictionary and Vectorization 
Studies in the medical area revealed, that topic 
quality can be improved by defining a dictionary 
containing relevant keywords, considered in the topic 
model as features [10]. As we did not have an existing 
dictionary of keywords for MS related social media 
content we used the YAKE! keyword extraction 
algorithm to obtain a keyword dictionary [33]. YAKE! 
is an unsupervised keyword extraction method, based 
on statistical text features to select the most relevant 
keywords of a text [33]. We decided to use 4200 
keywords after examining keywords. Subsequently, 
we cleaned the corpus of any words that did not 
represent keywords. To enable content analysis with 
Latent Dirichlet Allocation (LDA) we created a “Bag-
of-Words” vector representation. 
 
Bigram 
Bigrams consist of two words occurring very 
frequently in conjunction with one another. This 
feature transformation method can be used to improve 
topic coherence [34]. To create bigrams we used the 
genism´s “models.phrases()” function. 
 
Topic modeling  
Topic modeling refers to a class of statistical 
algorithms [35] used to infer abstract topics in a 
collection of text documents [27]. In our case, the 
collection of documents, D = {d1, d2,…, dn}, are users’ 
posts. To infer topics, Latent Dirichlet Allocation 
(LDA)-based topic modeling is applied, as it has 
already been used in similar scenarios [12, 14, 27]. In 
LDA topic modeling, each document consists of a 
mixture of topics, T = {t1, t2,…, tm}, described by 
discrete probability distributions θd [36]. Each topic 
consists of a mixture of vocabulary words, W = {w1, 
w2,…, wk}, described by a discrete probability 
distribution βt [36]. The generative process can be 
described as follows [35-37]:  
(1) For each topic t ∈ {1, …, m}, 
(a) draw a probability distribution over 
vocabulary words 
βt  ~ Dirichlet(η). 
(2) For each document d, 
(a) draw a vector of the topic probability 
distribution 
θd ~ Dirichlet(α). 
(b) For each word wi	 in document d, 
(i) draw a topic assignment 
zi ~ Multinomial(θd); 
(ii) draw a word wn  ~ Multinomial(βzi)	
 
The notations η and α represent the models’ 
hyperparameters to determine the Dirichlet 
distributions [37]. The LDA outputs are a topic-
document matrix and a topic-term matrix. The size of 
the topic-document matrix is n × m, with the weight 
wi,j being the association of a document di and a topic tj 
[36]. The topic-word matrix has the size m × k, the 
weight wi,j is the association of the topic ti and a word 
wj [36]. For practical implementation we used 
MALLET topic model python package which uses 
Gibbs sampling to estimate LDA parameters [38]. The 
number of topics must be determined a priori. To 
determine the optimal number of topics, we 
considered topic coherence measure by Roeder et al. 
[39] using the topic coherence pipeline of the Genism 
package and evaluated it using the elbow method [40] 
followed by manual evaluation by the authors. We 
decided for 39 topics and α of 0.0105 resulting in a 
topic coherence of 0.701.  
 
Computing importance 
The identified topics represent the UMNs. The 
importance of an UMN is calculated based on the 
frequency with which users mention the UMN in 
relation to all other UMNs (topic frequency).  
Therefore, the sum of the contribution 
probabilities of each UMN to all posts is a measure of 
the importance of the UMN within the collected 
corpus [27]. The importance scores of patient needs 
are scaled to a range of 0-10 obtaining values for the 
importance dimension of the OA [27]. 
3.2.2 Deriving satisfaction regarding UMNs 
Following the sentiment analysis pipeline is 
outlined, to create features for the “satisfaction” 
dimension of the OA. 
 
Unicode Transformation  
Unlike in topic modeling, the corpus was 
preprocessed only by data transformation of the text 
data into UTF-8 Unicode format. For example, 
tokenization and vectorization using the bag-of-words 
model is not necessary because the used sentiments 
analysis algorithm process continuous text data. 
 
Sentiment Analysis 
In order to derive user satisfaction regarding a 
certain topic, the corresponding sentiments have to be 
calculated using sentiment analysis [27]. Since 
sentiment analysis is broadly used to analyze the 
polarity of sentiment statements in social media posts 
a variety of methods exists [41]. It can be chosen of 
several rule-based and machine learning methods or a 
combination of both approaches [42]. We chose IBM 
Watson sentiment analysis because of the algorithm's 
proven track record in analyzing user sentiments in 
social media data [41, 43]. The sentiment analysis 
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algorithm is part of the IBM natural language 
understanding services and can be implemented due to 
application programming interface in python [41]. 
Outputs can be retrieved as JSON files containing an 
array of documents and corresponding sentiment score 
as continuous values. Sentiment scores ranging from 
−1 (negative) to 0 (neutral) to +1 (positive).  
 
Computing satisfaction 
Satisfaction is derived by the sentiment score 
[27]. Therefore, the sentiment score associated with 
each document is structured in an array. To calculate 
the sentiment score per topic, we multiply the 
sentiment document score by the weight of the topic's 
contribution to the document. Consequently, we 
obtain a sentiment-topic score by assigning a 
sentiment to each document, weighted by the topic-
document contribution. The satisfaction score 
regarding an UMN is the sum of sentiments of the 
sentiment-topic score. The satisfaction scores of 
patient needs are scaled to a range of 0-10 obtaining 
values for the satisfaction dimension of the OA [27]. 
3.3 Analysis of unmet medical needs using the 
opportunity algorithm 
Applying the OA to the importance and 
satisfaction scores, the innovation opportunity 
potential regarding a patients need is calculated [27, 
28]. The highest opportunities are represented by 
UMNs incorporating high importance and low 
satisfaction [27, 28]. According to the OA, such 
UMNs should be addressed in future drug 
development.  
4. Results: Identification and 
Prioritization of Unmet Medical Needs 
Following Wahbeh et al [36], the results are 
visualized using word clouds. The larger a given word 
the greater its contribution to the topic. The authors 
evaluated the word clouds independently to obtain the 
most reliable labels possible. Topics that were 
interpreted differently were discussed and re-
evaluated. In total 13 topics of 39 topics corresponded 
to UMNs of MS patients, belonging to the dimensions 
“symptom and disease burden”, “side effects” and 
“treatment inconvenience”[3]. Topic-document -
contribution matrix revealed that 32416 posts were 
dominated by UMN topics. Most UMNs belonging to 
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Topics corresponding to the dimension “symptom 
and disease burden are “pain”, “anxiety and 
depression”, “fatigue and dizziness”, “sleep-
disturbance and fatigue”, “cognitive impairment”, 
“sensory problems”, “bladder infection”, “vision 
problems” and “walking impairment”.  
Posts belonging to the topic “pain” were 
dominated by words such as “pain”, “muscle”, “leg” 
and “spasm” (Fig. 2). 
 
 
Figure 2. Topic “pain” 
 
Posts corresponding to the topic “word-finding-
problems” consisted of the terms “word”, 
“remember”, difficulty” and “talk” (Fig. 3). 
 
 
Figure 3. Topic “word-findings-problems” 
 
The topic “mental health” included posts, 
dominated by the words “anxiety”, “depression”, 





Figure 4. Topic “mental health” 
 
Posts belonging to the topic “fatigue and 
dizziness” were dominated by words such as 
“fatigue”, “dizziness” and “seizure” (Fig. 5). 
 
 
Figure 5. Topic “fatigue and dizziness” 
 
The topic “cognitive impairment” posts are 
dominated by word such as “cognitive”, “memory”, 
“change” and “learn” (Fig. 6). 
 
 
Figure 6. Topic “cognitive impairment” 
 
The topic “sensory problems” represents posts, 
dominated by the words “leg”, “hand”, “foot”, 




Figure 7. Topic “sensory problems” 
 
Posts belonging to the topic “bladder infection” 
are dominated by the terms “bladder”, “infection” and 
antibiotic” (Fig. 8). 
 
 
Figure 8. Topic “bladder infection” 
 
The topic “vision problems” included posts, 
dominated by the words “eye”, “vision” and 
“ophthalmologist” (Fig. 9). 
 
 
Figure 9. Topic “vision problems” 
 
Posts belonging to the topic “walking 
impairment” are dominated by the terms “walk”, 
“exercise”, “leg” and “strength” (Fig. 10). 
 
 
Figure 10. Topic “walking impairment” 
 
The topic “sleep-disturbance and fatigue” 
included posts, dominated by the words “sleep”, 
“fatique” and “wake” (Fig. 11). 
 
 
Figure 11. Topic “sleep-disturbance and 
fatigue” 
 
UMNs belonging to the dimension “side effects” 
are “flush and gastrointestinal problems” and 
“cancer”. 
The topic “flush and gastrointestinal problems” 
includes posts, dominated by the words “eat”, “flush”, 
“stomach”, “meal” and “food” (Fig. 12) 
 
 
Figure 12. Topic “flush and gastrointestinal 
problems” 
 
Posts belonging to the topic “cancer” are 
dominated by the terms “cancer”, “death”, “die” and 
“cure” (Fig. 13). 
 
 
Figure 13. Topic “cancer” 
 
UMN belonging to the dimension “Treatment 
inconvenience” is “route of administration: injection” 
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The topics “route of administration: injection” 
posts are dominated by word such as “injection”, 
“inject”, “shoot”, “needle” and “switch” (Fig. 14). 
 
 
Figure 14. Topic “route of administration: 
injection” 
 
4.1 Innovation opportunities for future 
treatments  
 
The results indicating that future treatments in MS 
should address UMNs in the dimension “symptoms 
and disease burden”, offering the most potential for 
improvement. The highest opportunity score (9.86) is 
assigned to “sensory problems”. This topic possesses 
the highest topic-document contribution among the 
UMN topics and therefore the highest level of 
importance (4.93). At the same time, among all topics, 
it possesses the lowest satisfaction score (0) (table 2). 
The following topics, ranked by the opportunity 
score, are “pain”, “sleep-disturbance and fatigue”, 
“bladder infection”, “walking impairment”, “Route of 
administration: injection”, “fatigue and dizziness”, 
“flush and gastrointestinal problems” (table 2). The 
results imply, that improvements in “cognitive 
impairment”, “vision problems” and “cancer” would 
not address relevant UMNs as the opportunity score 
results is negative, because of the low importance and 
relatively high satisfaction scores (table 2).  
 




Sensory problems 9.86 4.93 0 
Pain 7.37 3.9 0.43 
Sleep-disturbance and 
fatigue 
6.85 4.51 2.16 
Mental health 5.4 4.32 3.24 
Bladder infection 2.71 1.82 0.94 
Word-findings-problems 2.47 2.8 3.19 
Walking impairment 2.05 3.39 4.74 
Route of administration: 
injection 
1.85 2.26 2.67 
Fatigue & dizziness 0.36 0.78 1.2 
flush and gastrointestinal 
problems 
0.29 2.02 3.75 
Vision problems -0.7 0.74 2.2 
Cancer -1.39 0.81 3.03 
Cognitive impairment -4.15 0.23 4.6 
5. Discussion 
In the proposed study, we employed the 
opportunity algorithm to identify and prioritize unmet 
medical needs of multiple sclerosis patients. Using 
topic modeling and sentiment analysis features of the 
opportunity algorithm are generated. Identified UMNs 
were assigned to the dimensions “symptom and 
disease burden”, “side effects” and “treatment 
inconvenience”. Moreover, results are mostly 
consistent with findings in current MS-related 
research. For example, the OA results imply that pain, 
sensory issues, fatigue, and mental health issues 
(mainly consisting of the keywords “depression” and 
“anxiety”) represent a particularly high UMN. Green 
et al. [20] concluded by assessing UMNs due to a MS-
specific questionnaire, that pain, fatigue and walking 
impairment contribute the most to MS outpatient 
patient perceived health, followed by depression and 
anxiety. The similarity of the results demonstrates this 
methods potential to identify key UMNs and to 
achieve a reasonable ranking of symptoms and disease 
burden comparable to analogue methods. Differences 
in prioritization, such as the low ranking of walking 
disability compared to Green et al. could be explained 
by the choice of model parameters used and the 
selection of features considered. For example, a topic 
was detected that consisted of posts dominated by 
words such as "drive," "car," and "walk" - suggesting 
walking disability also causes severe limitations in 
automobility. Given our chosen UMN definition, we 
excluded this topic from our analysis. However, 
merging the "walking impairment" topic with the 
“automobility” topic into a general "mobility topic" 
would result in a higher prioritization and therefore be 
even more similar to the results of Green et al. [20] 
One way to accomplish this would have been to reduce 
the number of topics, resulting in fewer UMNs 
extracted overall. Hence, a key challenge is the 
definition of the model parameters. In this regard, it 
seems beneficial to involve medical domain experts 
for ensuring that the results are meaningful. Further 
identified symptoms such as word-findings problems 
[44], cognitive impairment [45], bladder infection [46] 
and vision problems [47] are also consisting with 
extant research. In the dimension “side effects” flush 
and gastrointestinal issues as well as cancer could be 
identified, which are already observed side effects [22, 
46], e.g. in treatments with dimethyl fumarate [48]. In 
accordance with the existing literature [22, 23], the 
route of administration by injection, has been 
indicated to be inconvenient as satisfaction score is 
rather low (table 2). Given the method used, 
information on immediate quality of life, mortality, or 
time of suffering in disease was not available. 
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Furthermore, many topics were found lying outside 
the conventional definition of UMNs.  For example, 
patients discussed topics such as insurance coverage, 
employment, or hospitalization. Whereas these topics 
were not included in our analysis as they were beyond 
the scope of our research question, it indicates this 
method could be used to gain a more comprehensive 
understanding of patients' needs. This study highlights 
the potential of social media mining for analyzing 
patients’ unmet medical needs. Given the combination 
of social media data and state-of-the-art analytics, as 
well as the need for increasing consideration of the 
patient perspective in drug development, we expect to 
witness an increasing use of similar approaches. 
Information could be used to align drug development 
with patient needs or to define endpoints in clinical 
trials that are relevant to patients. In addition, the 
proposed method could facilitate real-time tracking of 
patient needs as well as reduce costs associated with 
analog patient studies.  
5.1. Limitations 
In general, veracity of social media data for 
health-related analysis is limited. Since contributors 
such as patients are often lay persons using own 
definitions and terminologies the results can be biased. 
Comprehensive information on patient characteristics 
such as disease severity, concomitant diseases, site of 
care or medication use is not available. Moreover, data 
does not reveal a patient location. Therefore, we 
cannot conclude whether the identified UMN exists 
because no appropriate form of therapy is available or 
because the health care system does not provide 
access. Furthermore, MS includes different stages 
which is not considered in our analysis. Since results 
are based on social media posts from a publicly 
available online forum, results can be biased due to 
people participating in discussion but not suffering 
from MS, e.g., relatives of patients who searching for 
advice. The dataset consists of posts published during 
the years 2013 to 2020. Analysis was conducted using 
the data aggregated in its entirety. Therefore, it is 
uncertain whether the topic ranking reflects the current 
needs of patients. For instance, topic ranking could be 
biased by needs relevant to patients in the past, but 
already addressed due to pharmaceutical innovations 
and treatments available in the present. To enhance the 
distinction between past and current UMN, the 
opportunity algorithm might be applied using a 
smaller time interval. As all results were generated 
from the overall sample, robustness of the proposed 
algorithm needs to be proven. Regarding the topic 
model pipeline, spelling correction and the manual 
curation of the dictionary could improve results. The 
labeling of topics depends on subjective judgement. 
As topic models discard word order, location 
information is not available and causal inference is not 
possible, which is a significant limitation in drug 
development. Furthermore, a document-level 
sentiment analysis was used to calculate satisfaction 
regarding specific UMN topics. While the proposed 
method assigns a higher weight to relevant sentiment 
scores based on the document's contribution to the 
topic, a more detailed sentiment analysis could 
improve the results accuracy. For example, the more 
different topics are included in a document, the less 
accurate the document-level sentiment analysis is. In 
future research, we plan to apply keyword-level 
sentiment analysis to more accurately capture UMNs 
satisfaction. Since ground truth data on patient 
preferences is not available, limiting evaluation of the 
results, future studies should further assess the validity 
of the chosen method. For instance, the results of the 
proposed algorithm could be evaluated by comparing 
it to conventional and established methods of deriving 
patient needs, such as quality-of-life surveys or 
conjoint analysis.  
5.2. Conclusion 
Our study aimed to explore unmet medical needs 
in MS patient’s posts within an online disease forum 
employing social media mining methods. With the use 
of the opportunity algorithm, we were able to identify 
unmet medical needs, relevant from patients’ everyday 
perspective. Results of further automated 
prioritization are almost consistent with known needs 
of MS outpatients from extant research. The concrete 
results provide initial entry points for pharmaceutical 
innovation for MS patients in the areas of the most 
significant UMNs: sensory problems and pain, sleep 
problems and chronic fatigue, and mental health, each 
with an opportunity score above 5. 
This feasibility study demonstrates the potential 
of social media mining to generate relevant insights 
into hard to reach, rare disease populations to foster 
patient-centered drug development. The observed 
decline in the number of posts over the years indicates 
fewer users are participating in the online forum 
analyzed. Given the rise of social media platforms and 
MS online forums, we suggest patients are spreading 
across different online platforms, resulting in a 
decrease of active users and posts. To gain more 
comprehensive and reliable insights, data from 
multiple social media platforms should be combined 
by data fusion methods. 
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